Postgrad LIVE! Study Fairs

Southampton | Bristol

University of Leeds Featured PhD Programmes
University of Warwick Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Huddersfield Featured PhD Programmes
University of Nottingham Featured PhD Programmes

Breaking the HGF-cMET axis in medulloblastoma: development of small non-sugar glycosaminoglycan (GAG) mimics as anti-metastatic drugs.

  • Full or part time
  • Application Deadline
    Applications accepted all year round
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

Project Description

Medulloblastoma (MB) is the most common malignant paediatric brain tumour accounting for about 20% of all childhood brain cancers. Unfortunately, mortality from MB patients still remains significant and intensification of nonspecific therapy is unlikely to offer additional benefits, highlighting the need of new targeted therapies.

Experimental data have demonstrated that hepatocyte growth factor/Scatter factor (HGF/SF) and its receptor, the tyrosine kinase MET, act as powerful mediators for medulloblastoma cancer dissemination and its inhibition may represent a valuable strategy for targeted therapeutic intervention. In this collaborative project with our MedChem department, the candidate will identify and characterise new glycomimetics as inhibitors of the HGF-MET axis, advancing the discovery of a novel anti-metastatic targeted treatment to prevent metastatic spreading of medulloblastoma.

Funding Notes

This PhD is self-funded

Related Subjects

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully





FindAPhD. Copyright 2005-2019
All rights reserved.